Search research articles
Contact Us
Filters
Showing results (51-60 of 170) with videos related to
Page
of 17
Sort By:
Molecular Neurobiology
|
June 7, 2020
Ethanol-Induced Changes in Brain of Transgenic Mice Overexpressing DYRK1A
Marta Fructuoso, Yu Chen Gu, Nadim Kassis, et al.
Plos One
|
July 24, 2008
Impaired spatial learning strategies and novel object recognition in mice haploinsufficient for the dual specificity tyrosine-regulated kinase-1A (Dyrk1A)
Glòria Arqué, Vassiliki Fotaki, David Fernández, et al.
American Journal of Human Genetics
|
October 23, 2008
Targeting Dyrk1A with AAVshRNA attenuates motor alterations in TgDyrk1A, a mouse model of Down syndrome
Jon Ortiz-Abalia, Ignasi Sahún, Xavier Altafaj, et al.
Molecules (Basel, Switzerland)
|
March 18, 2015
Potential role of olive oil phenolic compounds in the prevention of neurodegenerative diseases
Jose Rodríguez-Morató, Laura Xicota, Montse Fitó, et al.
Cells
|
September 13, 2025
Astrocytopathy Is Associated with CA1 Synaptic Dysfunction in a Mouse Model of Down Syndrome
Álvaro Fernández-Blanco, Candela González-Arias, Cesar Sierra, et al.
Scientific Reports
|
February 8, 2017
New murine Niemann-Pick type C models bearing a pseudoexon-generating mutation recapitulate the main neurobehavioural and molecular features of the disease
Marta Gómez-Grau, Júlia Albaigès, Josefina Casas, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 12, 2010
Down syndrome: from understanding the neurobiology to therapy
Katheleen Gardiner, Yann Herault, Ira T Lott, et al.
Plos One
|
March 3, 2011
Behavioral characterization of a mouse model overexpressing DSCR1/ RCAN1
Mara Dierssen, Gloria Arqué, Jerome McDonald, et al.
Developmental Medicine and Child Neurology
|
January 24, 2023
State-of-the-art therapy for Down syndrome
Nicola Lorenzon, Juanluis Musoles-Lleó, Federica Turrisi, et al.
Neurobiology of Disease
|
October 26, 2005
Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models
Isidro Ferrer, Marta Barrachina, Berta Puig, et al.
Page
of 17
Search research articles
Search
Showing results (51-60 of 170) with videos related to
Sort By:
Page
of 17
Molecular Neurobiology
|
June 7, 2020
Ethanol-Induced Changes in Brain of Transgenic Mice Overexpressing DYRK1A
Marta Fructuoso, Yu Chen Gu, Nadim Kassis, et al.
Plos One
|
July 24, 2008
Impaired spatial learning strategies and novel object recognition in mice haploinsufficient for the dual specificity tyrosine-regulated kinase-1A (Dyrk1A)
Glòria Arqué, Vassiliki Fotaki, David Fernández, et al.
American Journal of Human Genetics
|
October 23, 2008
Targeting Dyrk1A with AAVshRNA attenuates motor alterations in TgDyrk1A, a mouse model of Down syndrome
Jon Ortiz-Abalia, Ignasi Sahún, Xavier Altafaj, et al.
Molecules (Basel, Switzerland)
|
March 18, 2015
Potential role of olive oil phenolic compounds in the prevention of neurodegenerative diseases
Jose Rodríguez-Morató, Laura Xicota, Montse Fitó, et al.
Cells
|
September 13, 2025
Astrocytopathy Is Associated with CA1 Synaptic Dysfunction in a Mouse Model of Down Syndrome
Álvaro Fernández-Blanco, Candela González-Arias, Cesar Sierra, et al.
Scientific Reports
|
February 8, 2017
New murine Niemann-Pick type C models bearing a pseudoexon-generating mutation recapitulate the main neurobehavioural and molecular features of the disease
Marta Gómez-Grau, Júlia Albaigès, Josefina Casas, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 12, 2010
Down syndrome: from understanding the neurobiology to therapy
Katheleen Gardiner, Yann Herault, Ira T Lott, et al.
Plos One
|
March 3, 2011
Behavioral characterization of a mouse model overexpressing DSCR1/ RCAN1
Mara Dierssen, Gloria Arqué, Jerome McDonald, et al.
Developmental Medicine and Child Neurology
|
January 24, 2023
State-of-the-art therapy for Down syndrome
Nicola Lorenzon, Juanluis Musoles-Lleó, Federica Turrisi, et al.
Neurobiology of Disease
|
October 26, 2005
Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models
Isidro Ferrer, Marta Barrachina, Berta Puig, et al.
Page
of 17